Corneal collagen cross-linking: A review of clinical applications
Publication in refereed journal


Times Cited
Altmetrics Information
.

Other information
AbstractCorneal collagen cross-linking (CXL) has been shown to slow down or stop the progression of keratoconus. In addition, CXL has been applied in cases of corneal ectasia. Recent reports of the use of CXL in cases of infectious keratitis have generated further interest in this treatment modality. This review discusses the principle, clinical uses, and complications associated with CXL.
All Author(s) ListXu K., Chan T.C.Y., Vajpayee R.B., Jhanji V.
Journal nameAsia-Pacific Journal of Ophthalmology
Year2015
Month1
Day1
Volume Number4
Issue Number5
PublisherLippincott Williams and Wilkins
Place of PublicationUnited States
Pages300 - 306
ISSN2162-0989
LanguagesEnglish-United Kingdom
KeywordsCorneal collagen cross-linking, Ectasia, Keratitis, Keratoconus

Last updated on 2021-24-02 at 01:35